Clinical Trials Logo

Clinical Trial Summary

The investigators will carry out a prospective cross-over, pre-and post-controlled clinical study : 36 patients with continuous ambulatory peritoneal dialysis with high/high average transport will be recruited and treated with continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis at night (using automatic peritoneal dialysis machine) for 1 month respectively. The changes of peritoneal transport function and ultrafiltration volume before and after the two dialysis methods will be compared.


Clinical Trial Description

1. Inclusion Criteria - Continuous ambulatory peritoneal dialysis for more than 3 months; - The peritoneal transport function is high/high average transport (D/Pcr>0.65 at 4 hours in the peritoneal balance test); - Sign the informed consent form voluntarily. 2. Exclusion Criteria - Patients with peritonitis in the past 3 months; - Patients with acute complications such as cardiovascular events, pulmonary infection and gastrointestinal bleeding in the past 3 months; - The doctor judged that it was not suitable for the patients in this study for other reasons. 3. Treatment plan The patients will be divided into two groups randomly: group A carry on continuous ambulatory peritoneal dialysis (the original dialysis plan) for 1 month, and then changed to intermittent peritoneal dialysis at night (using automatic peritoneal dialysis machine,the concentration and dosage of dialysate are consistent with the original plan) for 1 month; Group B carry on intermittent peritoneal dialysis at night (using automatic peritoneal dialysis machine,the concentration and dosage of dialysate are consistent with the original plan) for 1 month, and then change to continuous ambulatory peritoneal dialysis (original dialysis plan) for 1 month. 4. Observation indicators Main observation indicators: Changes in peritoneal transport rate (represented by 4-hour D/Pcr in the standard peritoneal balance test) and ultrafiltration volume (represented by 4-hour ultrafiltration volume in the standard peritoneal balance test) before and after daytime dry abdomen (intermittent peritoneal rest) and continuous peritoneal dialysis. Secondary outcome measures: changes in IL-1, IL-6 and TNF- α, VEGF and CTGF of the exudate in the standard peritoneal balance test before and after daytime dry abdomen (intermittent peritoneal rest) and continuous peritoneal dialysis . Changes of body weight, blood pressure, hemoglobin, albumin, calcium, phosphorus, electrolyte, urea clearance index, etc. before and after daytime dry abdomen (intermittent peritoneal rest) and continuous peritoneal dialysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05805813
Study type Interventional
Source Peking University People's Hospital
Contact Bei Wu, Doctor
Phone +8601088325429
Email wubei218@163.com
Status Recruiting
Phase N/A
Start date April 20, 2023
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT05465863 - Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases N/A
Recruiting NCT06126016 - A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Not yet recruiting NCT05234047 - Study Evaluating Denosumab on Vascular and Bone Metabolism in Osteoporotic Chronic Kidney Disease (HDENOBS)
Completed NCT04805632 - Immune Response in Dialysis Patients Vaccinated Against COVID-19
Completed NCT05729126 - The Discrepancy in Radiologists' Practice of Intravenous Contrast Imaging Studies Among Chronic Kidney Disease Patients
Completed NCT06394986 - Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
Recruiting NCT05071131 - Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease N/A
Recruiting NCT05549154 - A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation N/A
Not yet recruiting NCT06381076 - Examining the Impact of High-protein Oral Supplement With Liposomal Curcumin on Inflammation Markers and Oxidative Stress in Adults Undergoing Hemodialysis. N/A
Recruiting NCT05339009 - Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient